Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Second-generation antipsychotic discontinuation in first episode psychosis: an updated review.

Miller BJ, Bodenheimer C, Crittenden K.

Clin Psychopharmacol Neurosci. 2011 Aug;9(2):45-53. doi: 10.9758/cpn.2011.9.2.45. Epub 2011 Aug 31.

2.

A review of second-generation antipsychotic discontinuation in first-episode psychosis.

Miller BJ.

J Psychiatr Pract. 2008 Sep;14(5):289-300. doi: 10.1097/01.pra.0000336756.65308.83. Review.

PMID:
18832960
3.

Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review.

Karson C, Duffy RA, Eramo A, Nylander AG, Offord SJ.

Neuropsychiatr Dis Treat. 2016 Jan 6;12:57-67. doi: 10.2147/NDT.S96392. eCollection 2016. Review.

4.

Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis.

Alvarez-Jiménez M, Parker AG, Hetrick SE, McGorry PD, Gleeson JF.

Schizophr Bull. 2011 May;37(3):619-30. doi: 10.1093/schbul/sbp129. Epub 2009 Nov 9. Review.

5.

The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.

Kane JM, Leucht S, Carpenter D, Docherty JP; Expert Consensus Panel for Optimizing Pharmacologic Treatment of Psychotic Disorders.

J Clin Psychiatry. 2003;64 Suppl 12:5-19.

6.

Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era.

Alvarez-Jimenez M, O'Donoghue B, Thompson A, Gleeson JF, Bendall S, Gonzalez-Blanch C, Killackey E, Wunderink L, McGorry PD.

CNS Drugs. 2016 May;30(5):357-68. doi: 10.1007/s40263-016-0331-x.

PMID:
27106296
7.

Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial.

Wunderink L, Nieboer RM, Wiersma D, Sytema S, Nienhuis FJ.

JAMA Psychiatry. 2013 Sep;70(9):913-20. doi: 10.1001/jamapsychiatry.2013.19.

PMID:
23824214
8.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
9.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
10.

Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia : a 12- and 24-month follow-up from the e-STAR database in Spain.

Olivares JM, Rodriguez-Martinez A, Burón JA, Alonso-Escolano D, Rodriguez-Morales A; e-STAR Study Group.

Appl Health Econ Health Policy. 2008;6(1):41-53.

PMID:
18774869
11.

Utilization of long-acting antipsychotic medication in patient care.

Kane JM.

CNS Spectr. 2006 Dec;11(12 Suppl 14):1-7; quiz 7-8. Review.

PMID:
17146411
12.

Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherence.

Kelin K, Lambert T Jr, Brnabic AJ, Newton R, Ye W, Escamilla RI, Chen KP, Don L, Montgomery W, Karagianis J, Ascher-Svanum H.

Patient Prefer Adherence. 2011;5:213-22. doi: 10.2147/PPA.S16800. Epub 2011 May 9.

13.

[Atypical antipsychotics in first-episode psychosis: a review].

Rotgé JY, Aouizerate B, Tignol J.

Encephale. 2008 Apr;34(2):194-204. doi: 10.1016/j.encep.2007.07.003. Epub 2007 Oct 24. Review. French.

PMID:
18597729
14.

Long-acting injectable antipsychotics in the elderly: guidelines for effective use.

Masand PS, Gupta S.

Drugs Aging. 2003;20(15):1099-110. Review.

PMID:
14651433
15.

Views of early psychosis clinicians on discontinuation of antipsychotic medication following symptom remission in first episode psychosis.

Thompson A, Singh S, Birchwood M.

Early Interv Psychiatry. 2016 Aug;10(4):355-61. doi: 10.1111/eip.12244. Epub 2015 May 12.

PMID:
25962446
16.

Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome.

Wunderink L, Nienhuis FJ, Sytema S, Slooff CJ, Knegtering R, Wiersma D.

J Clin Psychiatry. 2007 May;68(5):654-61.

PMID:
17503973
17.

Long-acting Injectable Antipsychotics in First-episode Schizophrenia.

Jeong HG, Lee MS.

Clin Psychopharmacol Neurosci. 2013 Apr;11(1):1-6. doi: 10.9758/cpn.2013.11.1.1. Epub 2013 Apr 24.

18.

Role of long-acting injectable second-generation antipsychotics in the treatment of first-episode schizophrenia: a clinical perspective.

Přikryl R, Přikrylová Kučerová H, Vrzalová M, Cešková E.

Schizophr Res Treatment. 2012;2012:764769. doi: 10.1155/2012/764769. Epub 2012 May 7.

19.

Attitude toward antipsychotic medication as a predictor of antipsychotic treatment discontinuation in first-episode early-onset psychosis.

Fraguas D, Llorente C, Rapado-Castro M, Parellada M, Moreno D, Ruiz-Sancho A, Medina O, Alvarez-Segura M, de Castro MJ, Arango C.

Rev Psiquiatr Salud Ment. 2008 Dec;1(1):10-7. doi: 10.1016/S1888-9891(08)72511-4. Epub 2008 Dec 21. English, Spanish.

20.

Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.

Mayoral-van Son J, de la Foz VO, Martinez-Garcia O, Moreno T, Parrilla-Escobar M, Valdizan EM, Crespo-Facorro B.

J Clin Psychiatry. 2016 Apr;77(4):492-500. doi: 10.4088/JCP.14m09540.

PMID:
26759992
Items per page

Supplemental Content

Write to the Help Desk